Get started
NewGenIvf Group LimitedNewGenIvf Group LimitedNewGenIvf Group Limited

NewGenIvf Group Limited

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Seasonals

NIVF trade ideas

NIVF Easy win with upcoming mergerI believe this one has bottomed and is turning around. Look up latest reports, they will undergo a reverse merger, language below. Notably, the company had a meeting with NASDAQ today to determine their continued listing which I anticipate went well. NASDAQ will reply within a month, and the merger will take place by the end of Feb. finance.yahoo.com BANGKOK, Dec. 23, 2024 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ: NIVF) (“NewGen” or the “Company”) today announced that both parties involved in the previously announced reverse merger with European Wellness Investment Holdings Limited (“EWIHL”) have appointed legal counsel to prepare the Share Purchase Agreement (the “SPA”). Additionally, by mutual consent, the signing date for the SPA has been extended from January 27, 2025, to February 28, 2025. This extension will allow both parties sufficient time to complete the necessary due diligence, finalize the terms of the agreement, and ensure compliance with all relevant NASDAQ requirements for reverse mergers. This significant step follows the Company's prior announcement of a binding term sheet on December 11, 2024, which marked a pivotal moment in the Company's strategic partnership with EWIHL. This collaboration aims to leverage synergies between both companies to enhance service delivery and expand market reach in the healthcare sector. Mr. Siu Wing Fung Alfred, Founder, Chairman, and CEO of NewGen, commented: “We are excited about advancing this merger process as we continue building momentum toward completion. Engaging experienced legal counsel reflects our commitment to ensuring a seamless transaction process.” “This reverse merger represents a US$452 million transaction at a deemed price of US$3.20 per share —a significant milestone that we believe will enhance market visibility while supporting our continued listing on the Nasdaq Global Market. Additionally, this transaction satisfies all requirements necessary for maintaining our listing status ahead of our Nasdaq appeal hearing.”
NASDAQ:NIVFLong
by nothximgood
NIVF - Low Conviction; High Upside; Run just getting startLow Conviction play here at $1.34. Just broke out of the symetrial triangle this morning and high volume and has now retraced some. Chart looks super bullish and forming of a cup and handle. If this reverse merger goes through, look out above. BANGKOK, Thailand, April 22, 2024 (GLOBE NEWSWIRE) -- NewGenIvf Group (NASDAQ: NIVF) (“NewGen” or the “Company”), a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments, today announced the execution of a non-binding term sheet (the "Term Sheet") regarding a proposed reverse merger (the “Proposed Transaction”) with healthcare company European Wellness Investment Holdings Limited ("EWIHL"). Mr. Siu Wing Fung Alfred, Founder, Chairman, and CEO of NewGen commented, “I am thrilled to announce the signing of a non-binding term sheet with EWIHL, a leading healthcare company. The proposed reverse merger will bolster our position in several key ways. Operationally, it will unlock significant synergies, expand our global reach, and help us to further improve fertility outcomes for our customers. Financially, with the acquisition of a profitable business and a US$30 million fundraising, we will be well-equipped to fund our future growth. Moreover, the issuance of additional ordinary shares will increase our market capitalization, ensuring higher trading liquidity. Finally, I believe that the deemed price of US$5 per share confirms that our current share price is undervalued compared to the long-term fair valuation of the company.” The Proposed Transaction Pursuant to the Term Sheet, it is proposed that NewGen issue 53,600,000 of its ordinary shares to the shareholder(s) of EWIHL or its associate (the “EWIHL Shareholders”) in exchange for 100% equity interest of EWIHL, at a deemed price per share of US$5, representing an aggregate amount of US$268,000,000. Simultaneously, it is proposed that NewGen raise US$30 million from public or private shareholders, in a form mutually acceptable to both NewGen and EWIHL. Following stockholder approval of the Proposed Transaction, EWIHL Shareholders are expected to hold approximately 76.4% equity interest in NewGen. The Company expects to announce additional details regarding the Proposed Transaction when a definitive agreement is executed. The completion of the Proposed Transaction is subject to, among other matters, the completion of due diligence, the negotiation of a definitive agreement, obtaining adequate financing, satisfaction of the conditions negotiated therein, and approval of the Proposed Transaction by the board and stockholders, as and when applicable. There can be no assurance that a definitive agreement will be entered into or that the Proposed Transaction will be consummated on the terms or timeframe currently contemplated, or at all. www.globenewswire.com
NASDAQ:NIVFLong
by bettingbillions
NewGenIvf Group Limited (NIVF) - A Bullish Narrative EmergesThe recent price action of NewGenIvf Group Limited (NIVF) has unfolded a narrative of strong bullish sentiment, as evidenced by a suite of technical indicators and patterns. This analysis dissects the components contributing to the stock's present trajectory and endeavors to forecast potential entry and exit points for the speculative investor, always acknowledging the inherent risks of the market. Chart Composition and Indicators: Ichimoku Cloud: NIVF's price has breached the Ichimoku cloud, transitioning from a bearish to bullish market. The Conversion Line (2.05) now surpasses the Base Line (1.82), reinforcing the bullish sentiment. A sustained price above the cloud could suggest a robust uptrend. Volume: The volume spike aligns with a substantial price surge, indicating strong buying interest. An increase in volume during price advancements is a bullish confirmation. Relative Strength Index (RSI): The RSI, at a high level of 69.36, nears the overbought threshold, signaling strong buying pressure. However, investors should watch for potential retracements as values approach or exceed 70. Stochastic Oscillator: The Stochastic readings (14.13, 61.29, 65.15) are elevated, indicating momentum is on the side of the bulls, although nearing overbought conditions which could predicate a short-term pullback. Moving Average Convergence Divergence (MACD): The MACD line is above the signal line, which is bullish. However, the histogram shows diminishing momentum, hinting at potential consolidation or a slight price correction. Price Action and Candlestick Analysis: The candlesticks form a bullish pattern with a notable gap up, reflecting a strong buying interest. The latest candle, although red, has not invalidated the previous bullish candles, suggesting the pullback might be temporary. Price Targets and Speculation: Bullish Scenario: If the bullish momentum continues with support from the aforementioned indicators, we can speculate a near-term price target around the 78.60% Fibonacci retracement level at $2.46. Breaking above this level may lead to further bullish advancements towards the $2.95 zone (100.00% Fibonacci level), contingent on sustained volume and bullish indicator confirmations. Bearish Scenario: Should the stock reverse, a break below the Conversion Line ($2.05) may lead to a test of the Base Line ($1.82), which could act as a short-term support. Entry and Exit Strategies: Entry Point: Considering the bullish indicators, a speculative entry might be pursued if the stock experiences a minor pullback towards the Conversion Line ($2.05), which could provide a favorable risk-reward setup. Exit Point (Profit-Taking): Investors could consider taking profits near the $2.46 or $2.95 price levels, monitoring the RSI for overbought conditions and the MACD for signs of weakening momentum. Exit Point (Stop-Loss): A prudent stop-loss could be set just below the Base Line ($1.82) to minimize potential downside risk in the event of a trend reversal. Conclusion: NIVF's trajectory has encapsulated a classic bull's tale, buoyed by technical indicators and recent price action. Investors keen on capitalizing on this momentum should do so with calculated risk management, staying vigilant for signs of reversal that may warrant protective measures. Always remember, the markets are fertile grounds for speculation, not certainty.
NASDAQ:NIVF
by AxiomEx